$BIO The protocol sparked a rise in the decentralized science market, sending the ecosystem token surging +90% after the announcement of an AI-generated peptide to treat ADHD symptoms. This innovation shortened drug discovery timelines and shifted DeSci’s story to utility-driven investments.
of $BIO The token has skyrocketed from around $0.018 on April 13th to $0.038 as of today (April 16th), marking a +105% increase, with trading volume reaching $720 million against a market cap of $68 million.
🧵 Over 24 hours, our scientific team and infrastructure of AI scientists developed a new peptide agonist with the potential to treat ADHD.
Below is our paper on the pre-IND computational feasibility assessment of OX2R-004, an 18-residue peptide agonist designed as a selective OX2R… pic.twitter.com/LfqTELqlU1
— Paul Koolhaas Biography/acc (@paulkhls) April 13, 2026
By April 2026, the market capitalization of the DeSci sector will reach $315 million. $BIO It holds nearly 20% market share and serves as a liquidity anchor for BioDAO, which focuses on various health conditions.
Capital has rotated from meme coins to utility-focused tokens, with other DeSci participants such as Vibe, HairDAO, and ResearchHub posting significant gains as well. $BIO.
IP-$NFT Structure: How community-owned intellectual property funds biotechnology research and development
$BIO The protocol acts as a decentralized accelerator, providing a liquidity layer for BioDAO to fund early-stage research and manage intellectual property, bypassing traditional venture capital and big pharma gatekeeping.
At the heart of this model is IP.$NFTa tokenized representation of rights to specific scientific research that is collectively owned by DAO participants.
The publication of ADHD peptides demonstrates the potential of this protocol. An AI-powered drug discovery process identified peptides with the potential to improve ADHD symptoms, significantly speeding discovery compared to traditional methods.
Liquidity starts from the creation stage $BIO With token donations, the protocol facilitated over $50 million in research funding with support from Binance Labs in November 2024, demonstrating significant validation of the DeSci model.
🧪 DESCI Supercycle is here – why $BIO Up +30% today
Let me elaborate on this for G.
$BIO Volume was $271 million compared to a market cap of $54 million, an increase of 30%.
This is a volume to MCAP ratio of 495%
When volume is 5x market cap, someone knows something
Here’s what’s actually happening… pic.twitter.com/ydbfcWdFlU
— Mr. Brondor (@MrBrondorDeFi) April 15, 2026
Discover: Best Crypto Presales of 2026
DeSci’s competitive position: $BIO $350M Sector Comparison in Protocol and Reassessment
By March 2026, $BIO The token has fallen over 90% from a peak of $0.88 to around $0.018. This is a typical pattern for narrative-driven cycles.
$BIO This aligns with two key trends of 2026: decentralized science funding and tokenization of real-world assets, with AI playing a transformative role, especially in drug discovery. The company’s ADHD peptide announcement capitalized on this momentum.
As AI governance in healthcare and biotech strengthens, establishing an infrastructure for safety reviews is essential to building institutional trust in AI-driven discoveries. $BIOThe DAO is progressing towards clinical validation.
$BIO Protocol Market Snapshot: Key Indicators and Catalysts to Watch
$BIO We are aiming for 0.4. it’s just another thing $raveA play of style.
Alt season has arrived. Everyone, please fasten your seat belts.
only for $BTC Maintain over 72K, $BIO We will continue to push forward, aiming for even greater heights.$rave $BTC pic.twitter.com/69vZPkpjYz— Boss Chen Laoshi | FWA Trade Club (@0xchenlaoshi) April 16, 2026
Key technical levels indicated short-term support at $0.035 and resistance at $0.04, with the token trading at $0.038, an increase of +52% in 24 hours on April 16, 2026. Trading volume was $726 million against a market capitalization of $70 million, indicating a ratio of 10x.
Key catalysts to watch include exchange listings, “ignition sales,” and updates on ADHD peptide developments.
Attracting co-investment from traditional biotech and academic institutions will be key to distinguishing this DeSci cycle from previous hype phases. Future success will be $BIO The protocol’s funded science determines its upper limit.
Explore: The Best Meme Coins to Buy Now
Disclaimer: The author does not own or hold any securities discussed in the article. All stock prices are accurate at the time of writing.
